Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Primary Myelofibrosis × copanlisib × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 6 Neoplasm Metastasis 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Multiple Myeloma 2 Lymphoma, Follicular 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Spinocerebellar Degenerations 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Renal Insufficiency 1 Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Malignant Solid Neoplasm 1 Lymphoma, Mantle-Cell 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hepatic Insufficiency 1 Gallbladder Neoplasms 1 Digestive System Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

fludarabine phosphate 27 Cyclophosphamide 24 Whole-Body Irradiation 19 Mycophenolic Acid 19 Tacrolimus 16 Busulfan 16 ruxolitinib 15 Peripheral Blood Stem Cell Transplantation 14 Antilymphocyte Serum 14 fludarabine 13 Melphalan 12 Cyclosporine 10 thymoglobulin 9 Methotrexate 9 Sirolimus 6 Etoposide 6 Cord Blood Stem Cell Transplantation 6 Radiotherapy 5 Granulocyte Colony-Stimulating Factor 5 Stem Cell Transplantation 4 Cyclosporins 4 Azacitidine 4 pomalidomide 3 Surveys and Questionnaires 3 Rituximab 3 Prednisone 3 Filgrastim 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 parsaclisib 2 itacitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡